Profil
Thomas Rademacher is the founder and current Chief Executive Officer & Director of Emergex Vaccines Holding Ltd, which was founded in 2016.
Postes actifs de Thomas Rademacher
| Sociétés | Poste | Début |
|---|---|---|
Emergex Vaccines Holding Ltd.
 Emergex Vaccines Holding Ltd. Pharmaceuticals: MajorHealth Technology Emergex Vaccines Holding Ltd. is a biotechnology company, which engages in the development of medicines against viral and bacterial infectious diseases. It focuses on the vaccines for dengue fever, Zika, Ebola, pandemic flu, and serious intra-cellular bacterial infections. The company was founded by Storme Moore-Thornicroft and Thomas Rademacher in 2016 and is headquartered in Abingdon, the United Kingdom. | Fondateur | 01/01/2016 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Emergex Vaccines Holding Ltd.
Emergex Vaccines Holding Ltd. Pharmaceuticals: MajorHealth Technology Emergex Vaccines Holding Ltd. is a biotechnology company, which engages in the development of medicines against viral and bacterial infectious diseases. It focuses on the vaccines for dengue fever, Zika, Ebola, pandemic flu, and serious intra-cellular bacterial infections. The company was founded by Storme Moore-Thornicroft and Thomas Rademacher in 2016 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
